Reappraisal of the Impact of Race on Survival in Patients on Dialysis

American Journal of Kidney Diseases

Volumn 55, Issue 6, 2010, Pages 1102-1110

  Buckalew Jr , Vardaman M ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; chronic kidney disease; dialysis; European Americans; genetics; MYH9; race; survival

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIALYSIS; EUROPEAN AMERICAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; KIDNEY FAILURE; MORTALITY; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SURVIVAL RATE;

AFRICAN AMERICANS; CHRONIC DISEASE; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; KIDNEY DISEASES; RENAL DIALYSIS; SURVIVAL RATE;

EID: 77952552505     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.10.062     Document Type: Article

References (91)

1. Agodoa L., and Eggers P. Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial 20 (2007) 577-585
2. Xue J.L., Eggers P.W., Agodoa L.Y., Foley R.N., and Collins A.J. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries. J Am Soc Nephrol 18 (2007) 1299-1306
3. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
4. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
5. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
6. McClellan W., Warnock D.G., McClure L., et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17 (2006) 1710-1715
7. Newsome B.B., McClellan W.M., Allison J.J., et al. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction. Am J Kidney Dis 52 (2008) 251-261
8. Choi A.I., Rodriguez R.A., Bacchetti P., Bertenthal D., Hernandez G.T., and O'Hare A.M. White/black racial differences in risk of end-stage renal disease and death. Am J Med 122 (2009) 672-678
9. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 6 (1999) 461-470
10. Foley R.N., Murray A.M., Li S., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16 (2005) 489-495
11. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
12. Kovesdy C.P., Anderson J.E., Derose S.F., and Kalantar-Zadeh K. Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 4 (2009) 973-978
13. Hsu C.Y., Lin F., Vittinghoff E., and Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14 (2003) 2902-2907
14. Walker W.G., Neaton J.D., Cutler J.A., Neuwirth R., Cohen J.D., and The MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. JAMA 268 (1992) 3085-3091
15. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
16. Regalado M., Yang S., and Wesson D.E. Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35 (2000) 687-694
17. Brancati F.L., Whittle J.C., Whelton P.K., Seidler A.J., and Klag M.J. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 268 21 (1992) 3079-3084
18. Tarver-Carr M.E., Powe N.R., Eberhardt M.S., et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 13 (2002) 2363-2370
19. Appel L.J., Wright Jr. J.T., Greene T., et al. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med 168 (2008) 832-839
20. Rahman M., Pressel S., Davis B.R., et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 144 (2006) 172-180
21. Newsome B.B., McClellan W.M., Coffey C.S., Allison J.J., Kiefe C.I., and Warnock D.G. Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol 1 (2006) 993-999
22. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States (2008), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
23. Whittle J.C., Whelton P.K., Seidler A.J., and Klag M.J. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?. Arch Intern Med 151 (1991) 1359-1364
24. Southeastern Kidney Council Inc, ESRD Network 6. Annual Report (1993)
25. Cantor E.S., Kimmel P.L., and Bosch J.P. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151 (1991) 125-128
26. Seaquist E.R., Goetz F.C., Rich S., and Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320 18 (1989) 1161-1165
27. Freedman B.I., Tuttle A.B., and Spray B.J. Familial predisposition to nephropathy in African-Americans with non-insulin dependent diabetes mellitus. Am J Kidney Dis 25 (1995) 710-713
28. Lei H.H., Perneger T.V., Klag M.J., Whelton P.K., and Coresh J. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 9 7 (1998) 1270-1276
29. Freedman B.I., Spray B.J., Tuttle A.B., and Buckalew Jr. V.M. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21 (1993) 387-393
30. Freedman B.I., Volkova N.V., Satko S.G., et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 25 6 (2005) 529-535
31. Freedman B.I., Soucie J.M., Stone S.M., and Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34 2 (1999) 254-258
32. Freedman B.I., Wilson C.H., Spray B.J., Tuttle A.B., Olorenshaw I.M., and Kammer G.M. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 29 5 (1997) 729-732
33. Freedman B.I., Soucie J.M., and McClellan W.M. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 8 (1997) 1942-1945
34. Freedman B.I. Familial aggregation of end-stage renal failure: aetiological implications. Nephrol Dial Transplant 14 (1999) 295-297
35. Kopp J.B., Smith M.W., Nelson G.W., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40 (2008) 1175-1184
36. Kao W.H., Klag M.J., Meoni L.A., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40 (2008) 1185-1192
37. Freedman B.I., Hicks P.J., Bostrom M.A., et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75 (2009) 736-745
38. Freedman B.I., Hicks P.J., Bostrom M.A., et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant 24 11 (2009) 3366-3371
39. Pattaro C., Aulchenko Y.S., Isaacs A., et al. Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int 76 (2009) 297-306
40. Freedman B.I., Kopp J.B., Winkler C.A., et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN Study. Am J Nephrol 29 (2009) 626-632
41. Mesler D.E., McCarthy E.P., Byrne-Logan S., Ash A.S., and Moskowitz M.A. Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?. Am J Med 106 (1999) 300-306
42. Robinson B.M., Joffe M.M., Pisoni R.L., Port F.K., and Feldman H.I. Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol 17 (2006) 2910-2918
43. Pei Y.P., Greenwood C.M., Chery A.L., and Wu G.G. Racial differences in survival of patients on dialysis. Kidney Int 58 (2000) 1293-1299
44. Bleyer A.J., Tell G.S., Evans G.W., Ettinger W.H., and Burkart J.M. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 28 (1996) 72-81
45. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002) 2010-2019
46. Fink J.C., Burdick R.A., Kurth S.J., et al. Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34 (1999) 694-701
47. Kalantar-Zadeh K., Block G., Humphreys M.H., and Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 3 (2003) 793-808
48. Trivedi H., Xiang Q., and Klein J.P. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 24 (2009) 258-266
49. Obrador G.T., Arora P., Kausz A.T., Ruthazer R., Pereira B.J., and Levey A.S. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int 56 (1999) 2227-2235
50. Levine R.S., Foster J.E., Fullilove R.E., et al. Black-white inequalities in mortality and life expectancy, 1933-1999: implications for healthy people 2010. Public Health Rep 116 (2001) 474-483
51. Mensah G.A., Brown D.W., Croft J.B., and Greenlund K.J. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II). Am J Prev Med 29 (2005) 68-74
52. Geronimus A.T., Bound J., Waidmann T.A., Hillemeier M.M., and Burns P.B. Excess mortality among blacks and whites in the United States. N Engl J Med 335 (1996) 1552-1558
53. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 5 (2004) 1307-1315
54. Mehrotra R., Kermah D., Fried L., Adler S., and Norris K. Racial differences in mortality among those with CKD. J Am Soc Nephrol 19 (2008) 1403-1410
55. Young B.A., Rudser K., Kestenbaum B., Seliger S.L., Andress D., and Boyko E.J. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: the USRDS. Kidney Int 69 (2006) 1691-1698
56. Karnik J.A., Young B.S., Lew N.L., et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 60 (2001) 350-357
57. Bleyer A.J., Russell G.B., and Satko S.G. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55 (1999) 1553-1559
58. Cheung A.K., Sarnak M.J., Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58 (2000) 353-362
59. Stack A.G., and Bloembergen W.E. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12 (2001) 1516-1523
60. Volkova N., McClellan W., Soucie J.M., and Schoolwerth A. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant 21 (2006) 2202-2209
61. Trespalacios F.C., Taylor A.J., Agodoa L.Y., and Abbott K.C. Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62 (2002) 1799-1805
62. Marcantoni C., Ma L.J., Federspiel C., and Fogo A.B. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 62 (2002) 172-180
63. Fogo A., Breyer J.A., Smith M.C., et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 51 (1997) 244-252
64. Bleyer A.J., Chen R., D'Agostino Jr. R.B., and Appel R.G. Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 31 (1998) 28-34
65. Appel R.G., Bleyer A.J., and Burkart J.M. Does hypertension cause end-stage renal disease in older white patients?. Nephron 78 (1998) 332-333
66. Lipkowitz M.S., Iyengar S., Molineros J., et al. ; and AASK Investigators. Association analysis of the non-muscle myosin heavy chain 9 gene (MYH9) in hypertensive nephropathy: African American Study of Kidney Disease and Hypertension (AASK) [abstract]. J Am Soc Nephrol 20 (2009) 56A
67. Freedman B.I., and Sedor J.R. Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol 19 (2008) 2047-2051
68. Karter A.J., Ferrara A., Liu J.Y., Moffet H.H., Ackerson L.M., and Selby J.V. Ethnic disparities in diabetic complications in an insured population. JAMA 287 (2002) 2519-2527
69. Young B.A., Maynard C., and Boyko E.J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26 (2003) 2392-2399
70. Detrano R., Guerci A.D., Carr J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358 13 (2008) 1336-1345
71. Bild D.E., Detrano R., Peterson D., et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111 10 (2005) 1313-1320
72. Newman A.B., Naydeck B.L., Whittle J., Sutton-Tyrrell K., Edmundowicz D., and Kuller L.H. Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol 22 3 (2002) 424-430
73. Freedman B.I., Langefeld C.D., Lohman K.K., et al. Relationship between albuminuria and cardiovascular disease in type 2 diabetes. J Am Soc Nephrol 16 7 (2005) 2156-2161
74. Budoff M.J., Nasir K., Mao S., et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187 2 (2006) 343-350
75. Carnethon M.R., Bertoni A.G., Shea S., et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the Multiethnic Study of Atherosclerosis. Diabetes Care 28 (2005) 2768-2770
76. Gorelick P.B., Caplan L.R., Hier D.B., Parker S.L., and Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 34 (1984) 54-59
77. Inzitari D., Hachinski V.C., Taylor D.W., and Barnett H.J. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors?. Arch Neurol 47 (1990) 1080-1084
78. Gil-Peralta A., Alter M., Lai S.M., et al. Duplex Doppler and spectral flow analysis of racial differences in cerebrovascular atherosclerosis. Stroke 21 (1990) 740-744
79. Divers J., Wagenknecht L.E., Bowden D.W., et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: African American-Diabetes Heart Study. Diabetes Care 33 1 (2010) 131-138
80. Braun J., Oldendorf M., Moshage W., Heidler R., Zeitler E., and Luft F.C. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 27 (1996) 394-401
81. Russo D., Palmiero G., De Blasio A.P., Balletta M.M., and Andreucci V.E. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44 (2004) 1024-1030
82. Bellasi A., Veledar E., Ferramosca E., Ratti C., Block G., and Raggi P. Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile. Atherosclerosis 197 (2008) 242-249
83. Wagenknecht L.E., Bowden D.W., Carr J.J., Langefeld C.D., Freedman B.I., and Rich S.S. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 50 4 (2001) 861-866
84. Lange L.A., Bowden D.W., Langefeld C.D., et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 33 7 (2002) 1876-1881
85. Peyser P.A., Bielak L.F., Chu J.S., et al. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 106 3 (2002) 304-308
86. Wagenknecht L.E., Bertoni A.G., Divers J., et al. I. Correlates of coronary artery calcified plaque in African Americans and European Americans with diabetes [abstract]. Diabetes 58 suppl 1 (2009) A252
87. Schulz E., Arfai K., Liu X., Sayre J., and Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89 (2004) 4246-4253
88. Shao J.S., Cai J., and Towler D.A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26 (2006) 1423-1430
89. Gaillard T., Schuster D., and Osei K. Metabolic syndrome in black people of the African diaspora: the paradox of current classification, definition and criteria. Ethn Dis 19 suppl 2 (2009) S2-S7
90. Smith M.W., Patterson N., Lautenberger J.A., et al. A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet 74 (2004) 1001-1013
91. Divers J., Moossavi S., Langefeld C.D., and Freedman B.I. Genetic admixture: a tool to identify diabetic nephropathy genes in African Americans. Ethn Dis 18 (2008) 384-388